Belite Bio (BLTE) Tops Q3 EPS by 22c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts BLTE Hot Sheet
Join SI Premium – FREE
Belite Bio (NASDAQ: BLTE) reported Q3 EPS of ($0.28), $0.22 better than the analyst estimate of ($0.50).
For earnings history and earnings-related data on Belite Bio (BLTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agilysys, Inc. (AGYS) Tops Q2 EPS by 12c, Beats on Revenue; Offers FY27 Revenue Guidance
- Piper Sandler Assumes Par Pacific Holdings (PARR) at Neutral
- Clearwater Paper (CLW) Misses Q3 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
